Trial Details

TERMINATED
Basic Information
Clinical ID c1399
Identifier NCT02118584
Trial Title Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Ulcerative Colitis
Interventions DRUG: Etrolizumab
Participant Information
Sponsor Hoffmann-La Roche
City Birmingham
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2014-09-15
Primary Completion Date 2023-10-05
Completion Date 2023-10-05